1. Home
  2. SBMT vs KRRO Comparison

SBMT vs KRRO Comparison

Compare SBMT & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silver Bow Mining Corp. Common Shares

SBMT

Silver Bow Mining Corp. Common Shares

N/A

Current Price

$8.16

Market Cap

184.0M

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.81

Market Cap

187.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBMT
KRRO
Founded
N/A
2014
Country
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.0M
187.9M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
SBMT
KRRO
Price
$8.16
$13.81
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
89.6K
68.7K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.31
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$25.97
N/A
Revenue Growth
N/A
181.46
52 Week Low
$5.75
$5.20
52 Week High
$9.48
$55.89

Technical Indicators

Market Signals
Indicator
SBMT
KRRO
Relative Strength Index (RSI) 44.00 53.09
Support Level $6.03 $12.63
Resistance Level $8.00 $14.42
Average True Range (ATR) 0.48 0.85
MACD -0.13 -0.02
Stochastic Oscillator 0.58 65.67

Price Performance

Historical Comparison
SBMT
KRRO

About SBMT Silver Bow Mining Corp. Common Shares

Silver Bow Mining Corp is engaged in the acquisition, exploration, and development of mineral resource properties in Butte, Montana, USA. The Company's primary business objective is to identify and evaluate prospective properties with the potential for future extraction and commercialization.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: